Novel Nonphosphorylated Serine 9/21 GSK3β/a Antibodies: Expanding the Toolkit for Studying GSK3 Regulation
Glycogen synthase kinase 3 (GSK3) and are serine/threonine kinases involved in many biological processes. A primary mechanism of GSK3 activity regulation is phosphorylation of N-terminal serine (S) residues (S9 in GSK3b, S21 in GSK3a). Phosphorylation is inhibitory to GSK3 kinase activity because...
Main Authors: | Tessa Grabinski, Nicholas M Kanaan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2016.00123/full |
Similar Items
-
Glycogen synthase kinase 3 (GSK-3) and its inhibitors : drug discovery and development /
by: Martinez, Ana, 1961-, et al.
Published: (2006) -
The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
by: Ata ur Rahman Mohammed Abdul, et al.
Published: (2018-01-01) -
Effects of GSK-3 inhibition on LPS-induced neuroinflammation and IL-10 production in microglia
by: Md Zain, Zuhaida
Published: (2016) -
GSK-3 protein and the heart: friend or foe?
by: B. Huisamen, et al.
Published: (2017-04-01) -
GSK3β Inhibition Ameliorates Atherosclerotic Calcification
by: Xinjiang Cai, et al.
Published: (2023-07-01)